[go: up one dir, main page]

PE20210441A1 - Carboxialquilo de quitosano - Google Patents

Carboxialquilo de quitosano

Info

Publication number
PE20210441A1
PE20210441A1 PE2020000623A PE2020000623A PE20210441A1 PE 20210441 A1 PE20210441 A1 PE 20210441A1 PE 2020000623 A PE2020000623 A PE 2020000623A PE 2020000623 A PE2020000623 A PE 2020000623A PE 20210441 A1 PE20210441 A1 PE 20210441A1
Authority
PE
Peru
Prior art keywords
carboxialkyl
chitosane
rheumatological
ophthalmological
carboxyalkyl
Prior art date
Application number
PE2020000623A
Other languages
English (en)
Inventor
Mickael Chausson
Pierre Douette
Sandrine Gautier
Philippe Vaesen
Houtai Choumane
Guillermo Rocasalbas
Original Assignee
Kiomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=61802047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20210441(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiomed Pharma filed Critical Kiomed Pharma
Publication of PE20210441A1 publication Critical patent/PE20210441A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un carboxialquilo de quitosano, a las composiciones que lo comprenden, a su procedimiento de fabricacion, y a sus diferentes aplicaciones, en particular, en el campo terapeutico, reumatologico, oftalmologico, de la medicina estetica, cirugia plastica, cirugia interna, dermatologico, o cosmetica.
PE2020000623A 2017-11-28 2018-11-09 Carboxialquilo de quitosano PE20210441A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1761323A FR3074044B1 (fr) 2017-11-28 2017-11-28 Carboxyalkyl chitosane
PCT/EP2018/080767 WO2019105719A1 (fr) 2017-11-28 2018-11-09 Carboxyalkyl chitosane

Publications (1)

Publication Number Publication Date
PE20210441A1 true PE20210441A1 (es) 2021-03-08

Family

ID=61802047

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2020000623A PE20210441A1 (es) 2017-11-28 2018-11-09 Carboxialquilo de quitosano

Country Status (20)

Country Link
US (2) US11667727B2 (es)
EP (1) EP3510051B2 (es)
AR (1) AR115049A1 (es)
CA (1) CA3082557A1 (es)
CL (1) CL2020001323A1 (es)
DK (1) DK3510051T3 (es)
EA (1) EA202091062A1 (es)
ES (1) ES2781787T5 (es)
FI (1) FI3510051T4 (es)
FR (1) FR3074044B1 (es)
HR (1) HRP20200411T4 (es)
MA (1) MA49811A1 (es)
MX (1) MX2020005002A (es)
PE (1) PE20210441A1 (es)
PL (1) PL3510051T5 (es)
PT (1) PT3510051T (es)
SG (1) SG11202005039WA (es)
TN (1) TN2020000070A1 (es)
UA (1) UA126087C2 (es)
WO (1) WO2019105719A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112111022B (zh) * 2020-10-10 2021-06-04 山东一滕新材料股份有限公司 一种改性壳聚糖及其制备方法、瓷砖胶添加剂及其应用
FR3116534B1 (fr) * 2020-11-23 2023-12-22 Kiomed Pharma Billes à base de chitosane, préparation, compositions et applications

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619995A (en) * 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
US5679658A (en) * 1995-05-08 1997-10-21 Chitogenics, Inc. N,O-carbonxymethylchitosan for prevention of surgical adhesions
DE19725037B4 (de) 1997-06-13 2004-08-05 Cognis Deutschland Gmbh & Co. Kg Chitinderivate, Verfahren zu deren Herstellung und deren Verwendung
US6645947B1 (en) * 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
BE1014638A6 (fr) 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
CN1193044C (zh) 2003-01-09 2005-03-16 武汉大学 羧甲基壳聚糖的制备方法
WO2005051326A2 (en) 2003-11-24 2005-06-09 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of compounds and methods of use thereof
BE1016383A3 (fr) 2004-12-15 2006-10-03 Physiol Composition polymere pour lentille intraoculaire.
US8153612B2 (en) * 2006-12-11 2012-04-10 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
CN102688195B (zh) 2012-06-06 2014-01-08 中国海洋大学 一种具有pH敏感性的包载盐酸阿霉素的壳聚糖羧甲基壳聚糖纳米缓释微粒的制备方法
CN103937014B (zh) 2014-04-10 2016-05-25 北京爱美客生物科技有限公司 壳聚糖双网络快速响应型可注射水凝胶及其制备方法
FR3024363B1 (fr) * 2014-08-01 2018-08-10 Synolyne Pharma Composition thermogelifiable
FR3024362A1 (fr) 2014-08-01 2016-02-05 Synolyne Pharma Sa Composition thermogelifiable sterilisee
FR3029116B1 (fr) 2014-12-01 2018-03-30 Advanced Chitosan Solutions Biotech Procede d'obtention d'un gel de cartilage pour la reparation cartilagineuse, comprenant du chitosane et des chondrocytes
FR3038838B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
FR3038837B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
CN106474569B (zh) 2016-12-02 2019-04-09 上海其胜生物制剂有限公司 一种羧甲基几丁质临界水凝胶的制备方法
CN107325306B (zh) 2017-06-13 2019-10-25 爱美客技术发展股份有限公司 壳聚糖或其衍生物多重交联凝胶和制备方法
FR3116534B1 (fr) 2020-11-23 2023-12-22 Kiomed Pharma Billes à base de chitosane, préparation, compositions et applications

Also Published As

Publication number Publication date
ES2781787T3 (es) 2020-09-07
EP3510051B2 (fr) 2022-10-05
CA3082557A1 (fr) 2019-06-06
US20210171667A1 (en) 2021-06-10
US11667727B2 (en) 2023-06-06
AR115049A1 (es) 2020-11-25
UA126087C2 (uk) 2022-08-10
SG11202005039WA (en) 2020-06-29
EP3510051A1 (fr) 2019-07-17
DK3510051T3 (da) 2020-03-16
PL3510051T5 (pl) 2023-01-30
MA49811A1 (fr) 2020-10-28
HRP20200411T4 (hr) 2022-11-25
FR3074044B1 (fr) 2019-11-01
ES2781787T5 (es) 2023-02-27
EP3510051B1 (fr) 2020-01-01
WO2019105719A1 (fr) 2019-06-06
PL3510051T3 (pl) 2020-11-02
PT3510051T (pt) 2020-04-06
FI3510051T4 (en) 2022-12-15
MX2020005002A (es) 2020-08-27
FR3074044A1 (fr) 2019-05-31
EA202091062A1 (ru) 2020-08-07
US20230174682A1 (en) 2023-06-08
TN2020000070A1 (fr) 2022-01-06
CL2020001323A1 (es) 2020-09-11
HRP20200411T1 (hr) 2020-06-12

Similar Documents

Publication Publication Date Title
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
IL273177B (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
EP3672587A4 (en) PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF OPHTHALMIC DISORDERS
EP3474869A4 (en) COMPOSITIONS OF HUMAN TISSUE AND USES THEREOF
HUE062511T2 (hu) Alzheimer-kór kezelése egy adott betegpopulációban
EA201500873A1 (ru) Антимикробные композиции и способы их применения
EP3721890A4 (en) OPHTHALMIC DRUG PREPARATION AND ITS USES
MX2017001746A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
CL2020001322A1 (es) Quitosano con carga aniónica.
CL2020001323A1 (es) Carboxialquilo de quitosano.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
EP3600324A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
EP3586843A4 (en) GLAUCOCALYXIN A DERIVATIVE, A PHARMACEUTICALLY ACCEPTABLE SALT OF IT, OR PHARMACEUTICAL COMPOSITION OF IT AND ITS USES IN THE PREPARATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PSORIASIS
IL271592A (en) The compounds that combine an anti-inflammatory drug and the action of Dicer for the treatment of neurological diseases.
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych
EP3265108A4 (en) PEPTIDES AND COMPOSITIONS AS WELL AS USES THEREOF IN THE TREATMENT OF DISEASES
Winter et al. Simulation training in burns
EP3773932A4 (en) SKIN CARE COMPOSITIONS AND THEIR APPLICATIONS
EP3461490C0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HAEMORROID DISEASE
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
EP3345612A4 (en) USE OF BACTERIORHODOPSIN AS COSMETICS AND / OR THERAPEUTICS FOR COMPREHENSIVE TREATMENT OF DERMATOSES
MX2017011903A (es) Composiciones para el tratamiento de enfermedades renales y/o hepaticas.
IT201700047210A1 (it) Composizione cosmetica e/o dermatologica, e suoi usi in campo cosmetico e nel trattamento coadiuvante di patologie dermatologiche
CO2017006842A1 (es) Equipo biomedico electromagnetico